Figure 1.

Subsequent survival and cause-specific survival in patients with advanced Waldenström macroglobulinemia according to the International Scoring System risk evaluated at the time of salvage therapy. (A) Survival: P value was 0.046 for the overall comparison of the 3 subgroups and 0.019 for the comparison of high-risk and remaining patients (intermediate or low-risk). (B) Cause-specific survival. P value was 0.05 for the comparison of high-risk and remaining patients (intermediate or low-risk).